Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibodies specific for IL20-Rb, encoding nucleic acids thereof and methods of use thereof to treat bacterial-induced exacerbation of chronic obstructive pulmonary disease

Monoclonal antibodies specific for IL20-Rb, encoding nucleic acids thereof and methods of use thereof to treat bacterial-induced exacerbation of chronic obstructive pulmonary disease

US Patent 12460009 · Granted Nov 4, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-müllerian inhibiting substance antibodies and uses thereof2025
Anti-müllerian inhibiting substance antibodies and uses thereof2025
Anti-müllerian inhibiting substance antibodies and uses thereof2025
Treatment of acute exacerbations of chronic obstructive pulmonary disease by ant2025
Treatment of acute exacerbations of chronic obstructive pulmonary disease by ant2025
Monoclonal antibodies binding to the CD160 transmembrane isoform2021
Monoclonal antibodies binding to the CD160 transmembrane isoform2021
Monoclonal antibodies binding to the CD160 transmembrane isoform2021
Methods and pharmaceutical compositions for the treatment of pulmonary bacterial2021
Methods and pharmaceutical compositions for the treatment of pulmonary bacterial2021
Human monoclonal antibodies against orexin receptor type 12020
Human monoclonal antibodies against orexin receptor type 12020